Chromatography-Free Purification of Biological Macromolecular Complexes
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for purifying biological macromolecular complexes, such as chromatography, are laborious, expensive, and often result in macromolecules that are not suitable for further analysis, particularly for structural determination and functional studies, due to their instability and compositional complexity.
Innovation Solution
A method involving centrifugation steps with osmolytes and water-soluble polymers like polyalkylene glycol for precipitation, followed by density gradient centrifugation, allowing for chromatography-free purification and crystallization of biological macromolecular complexes, maintaining their stability and functionality.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If chromatography methods are used for purification, then separation purity is improved, but process complexity and cost increase
Solution Approach 1:
The patent changes the physical parameters of the system by using density gradient centrifugation instead of chromatography. The purification is achieved by exploiting density differences through centrifugal force, transforming the separation mechanism from chemical/affinity-based (chromatography) to physical density-based (centrifugation), thereby simplifying the process while maintaining high purity
Solution Approach 2:
The patent replaces the complex chromatography system with a mechanical centrifugation system. Instead of using chromatography columns, resins, and flow systems, the invention uses centrifugal separation with density gradients, substituting a mechanically simpler system that achieves equivalent or superior purification results
2Manufacturing precision
If chromatography steps are applied, then separation capability is improved, but time consumption and cost increase
Solution Approach 1:
The patent extracts and eliminates the chromatography steps from the purification protocol, retaining only the essential separation functionality through density gradient centrifugation. This extraction of the problematic element (chromatography) while preserving the desired outcome (separation purity) directly reduces time consumption and cost
3Quantity of substance
If conventional purification methods are used, then macromolecular complexes are obtained, but their stability and functionality deteriorate
Solution Approach 1:
The patent creates an inert environment for the macromolecular complexes by using a density gradient medium that maintains physiological conditions throughout the centrifugation process. The gradient buffer system provides a protective environment that prevents denaturation and maintains stability, analogous to creating an inert atmosphere that protects sensitive materials from degradation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides high-purity, stable biological macromolecular complexes suitable for crystallization and structural analysis, enabling diffraction data collection at resolutions below 2.2 Å, facilitating the identification of suitable ligands and inhibitors for therapeutic applications in personalized medicine.
Implementation Method 1
treating the supernatant obtained from the second centrifugation step with a water-soluble polymer, in particular, a non-ionic polymer or a polymer with zero net charge, like polyalkylene glycol, polyamine, or polycarboxylate for precipitation
Implementation Method 2
conducting a density gradient centrifugation using an osmolyte with the polymer-based precipitate
Implementation Method 3
conducting a first centrifugation step for separation of cell debris at 25.000 to 35.000×g; conducting a second centrifugation step by centrifugation at 50.000 to 150.000×g
Data Source
AI summary
The present invention relates in a first aspect to a method for the purification of biological macromolecular complexes. Typically, no chromatography steps are applied. That is, the present invention relates to a method for the purification of biological macromolecular complexes Furthermore, the present invention relates to a method for crystallization of biological macromolecular complexes comprising the step of purification as described followed by crystallization in a reservoir solution containing a water-soluble polymer. Furthermore, purified biological macromolecular complexes obtainable by the method according to the present invention are provided as well as crystallized biological macromolecular complexes. Finally, a method for determining the suitability of a candidate compound for inhibiting the 20S proteasome of an individual is provided. Said method is particularly useful in personalized medicine identifying suitable inhibitors of the 20S proteasome in individuals for treating, ameliorating or preventing a cancer, an autoimmune disease, a muscular dystrophy, emphysema or cachexia accompanying cancer or AIDS.